1. Home
  2. TIL vs NAAS Comparison

TIL vs NAAS Comparison

Compare TIL & NAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • NAAS
  • Stock Information
  • Founded
  • TIL 2018
  • NAAS 2019
  • Country
  • TIL United States
  • NAAS China
  • Employees
  • TIL N/A
  • NAAS N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • NAAS Other Specialty Stores
  • Sector
  • TIL Health Care
  • NAAS Consumer Discretionary
  • Exchange
  • TIL Nasdaq
  • NAAS Nasdaq
  • Market Cap
  • TIL 230.1M
  • NAAS 8.3M
  • IPO Year
  • TIL 2021
  • NAAS 2017
  • Fundamental
  • Price
  • TIL $23.81
  • NAAS $0.81
  • Analyst Decision
  • TIL Buy
  • NAAS
  • Analyst Count
  • TIL 5
  • NAAS 0
  • Target Price
  • TIL $119.00
  • NAAS N/A
  • AVG Volume (30 Days)
  • TIL 334.3K
  • NAAS 1.6M
  • Earning Date
  • TIL 08-12-2025
  • NAAS 07-23-2025
  • Dividend Yield
  • TIL N/A
  • NAAS N/A
  • EPS Growth
  • TIL N/A
  • NAAS N/A
  • EPS
  • TIL N/A
  • NAAS N/A
  • Revenue
  • TIL N/A
  • NAAS $43,258,393.00
  • Revenue This Year
  • TIL N/A
  • NAAS $19.53
  • Revenue Next Year
  • TIL N/A
  • NAAS $151.36
  • P/E Ratio
  • TIL N/A
  • NAAS N/A
  • Revenue Growth
  • TIL N/A
  • NAAS 50.34
  • 52 Week Low
  • TIL $9.62
  • NAAS $0.60
  • 52 Week High
  • TIL $92.00
  • NAAS $41.80
  • Technical
  • Relative Strength Index (RSI)
  • TIL 45.83
  • NAAS 35.20
  • Support Level
  • TIL $20.60
  • NAAS $0.60
  • Resistance Level
  • TIL $31.67
  • NAAS $0.91
  • Average True Range (ATR)
  • TIL 3.53
  • NAAS 0.12
  • MACD
  • TIL -1.54
  • NAAS 0.00
  • Stochastic Oscillator
  • TIL 17.93
  • NAAS 30.99

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About NAAS NaaS Technology Inc.

Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators. wide range of offline services that simplify the daily operations of charging station operators, and of non-charging services such as food and beverage services to station operators.

Share on Social Networks: